Application and synthesis of thiazole ring in clinically approved drugs

ZX Niu, YT Wang, SN Zhang, Y Li, XB Chen… - European Journal of …, 2023 - Elsevier
The development of heterocyclic derivatives has progressed considerably over the past few
decades, and many new agents of synthetic and natural origin have been produced. Among …

Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney …

RJ Johnson, GL Bakris, C Borghi, MB Chonchol… - American Journal of …, 2018 - Elsevier
Urate is a cause of gout, kidney stones, and acute kidney injury from tumor lysis syndrome,
but its relationship to kidney disease, cardiovascular disease, and diabetes remains …

Renal autoregulation in health and disease

M Carlström, CS Wilcox… - Physiological …, 2015 - journals.physiology.org
Intrarenal autoregulatory mechanisms maintain renal blood flow (RBF) and glomerular
filtration rate (GFR) independent of renal perfusion pressure (RPP) over a defined range (80 …

Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled …

D Sircar, S Chatterjee, R Waikhom, V Golay… - American Journal of …, 2015 - Elsevier
Background Hyperuricemia is a putative risk factor for the progression of chronic kidney
disease (CKD). We hypothesized that control of asymptomatic hyperuricemia may slow …

Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study

M Kuwabara, K Niwa, I Hisatome, T Nakagawa… - …, 2017 - Am Heart Assoc
Whether asymptomatic hyperuricemia in the absence of comorbidities increases the risk for
cardiometabolic disorders and chronic kidney disease remains controversial. This study was …

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

RJ Johnson, SE Perez-Pozo, YY Sautin… - Endocrine …, 2009 - academic.oup.com
We propose that excessive fructose intake (> 50 g/d) may be one of the underlying etiologies
of metabolic syndrome and type 2 diabetes. The primary sources of fructose are sugar …

Uric acid as a target of therapy in CKD

DI Jalal, M Chonchol, W Chen, G Targher - American journal of kidney …, 2013 - Elsevier
The prevalence of chronic kidney disease (CKD) has increased and will continue to
increase in the United States and worldwide. This is alarming considering that CKD is an …

Heat stress nephropathy from exercise-induced uric acid crystalluria: a perspective on Mesoamerican nephropathy

C Roncal-Jimenez, R García-Trabanino… - American journal of …, 2016 - Elsevier
Mesoamerican nephropathy (MeN), an epidemic in Central America, is a chronic kidney
disease of unknown cause. In this article, we argue that MeN may be a uric acid disorder …

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis

B Bose, SV Badve, SS Hiremath… - Nephrology Dialysis …, 2014 - academic.oup.com
Background Non-randomized studies suggest an association between serum uric acid
levels and progression of chronic kidney disease (CKD). The aim of this systematic review is …

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis

T Kanji, M Gandhi, CM Clase, R Yang - BMC nephrology, 2015 - Springer
Background Hyperuricemia may contribute to renal injury. We do not know whether use of
treatments that lower urate reduce the progression of chronic kidney disease (CKD) and …